However, other studies in different tumour types have reported contradicting clinical effects of TERT promoter mutations, ranging from poorer survival associated with the -146 C>T TERT promoter mutation to unchanged clinical outcome (28, 29, 32, 51–54). The gene discussed is TERT; the disease is neoplasm.